10-Q Filing

IDT CORP CIK: 1005731 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001213900-18-002826`
Period End Date	20180131
Filing Date	20180312
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	idt-20180131.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 84 Cash Flow Statement 84 Comprehensive Income 28

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$2.64M	USD	Point-in-time
Allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$2.66M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$54.05M	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$90.34M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$46.20M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$58.27M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Trade accounts receivable, net of allowance for doubtful accounts of $2,642 at January 31, 2018 and $2,657 at July 31, 2017	`ReceivablesNetCurrent`	$64.98M	USD	Point-in-time
Trade accounts receivable, net of allowance for doubtful accounts of $2,642 at January 31, 2018 and $2,657 at July 31, 2017	`ReceivablesNetCurrent`	$71.65M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$15.91M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$14.51M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$18.75M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$30.73M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$124.27M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$138.70M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$371.12M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$357.26M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$88.99M	USD	Point-in-time
Property, plant and equipment, net	`PropertyPlantAndEquipmentNet`	$88.62M	USD	Point-in-time
Goodwill	`Goodwill`	$11.45M	USD	Point-in-time
Goodwill	`Goodwill`	$11.33M	USD	Point-in-time
Investments	`LongTermInvestments`	$24.35M	USD	Point-in-time
Investments	`LongTermInvestments`	$26.89M	USD	Point-in-time
Deferred income tax assets, net	`DeferredTaxAssetsNetNoncurrent`	$11.84M	USD	Point-in-time
Deferred income tax assets, net	`DeferredTaxAssetsNetNoncurrent`	$8.65M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.66M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$8.62M	USD	Point-in-time
Assets held for sale	`DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets`	$5.13M	USD	Point-in-time
Assets held for sale	`DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets`	$5.29M	USD	Point-in-time
Total assets	`Assets`	$504.23M	USD	Point-in-time
Total assets	`Assets`	$518.96M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$40.99M	USD	Point-in-time
Trade accounts payable	`AccountsPayableCurrent`	$37.07M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$125.36M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$113.15M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$71.79M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$76.45M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$4.66M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$4.68M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$129.42M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$115.32M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$356.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$362.78M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.11M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.08M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$642.00K	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$550.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$357.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$364.41M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.01 par value; authorized shares-10,000; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.01 par value; authorized shares-10,000; no shares issued	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$396.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$394.46M	USD	Point-in-time
Treasury stock, at cost, consisting of 1,698 and 1,698 shares of Class A common stock and 2,302 and 2,297 shares of Class B common stock at January 31, 2018 and July 31, 2017, respectively	`TreasuryStockValue`	$83.30M	USD	Point-in-time
Treasury stock, at cost, consisting of 1,698 and 1,698 shares of Class A common stock and 2,302 and 2,297 shares of Class B common stock at January 31, 2018 and July 31, 2017, respectively	`TreasuryStockValue`	$83.36M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.34M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-173.39M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-163.37M	USD	Point-in-time
Total IDT Corporation stockholders' equity	`StockholdersEquity`	$137.27M	USD	Point-in-time
Total IDT Corporation stockholders' equity	`StockholdersEquity`	$145.73M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$9.09M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$8.82M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$146.36M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$154.56M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$504.23M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$518.96M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$395.88M	USD	1 Quarter
Revenues	`Revenues`	$789.44M	USD	2 Qtrs
Revenues	`Revenues`	$736.71M	USD	2 Qtrs
Revenues	`Revenues`	$367.56M	USD	1 Quarter
Direct cost of revenues (exclusive of depreciation and amortization)	`CostOfRevenue`	$310.91M	USD	1 Quarter
Direct cost of revenues (exclusive of depreciation and amortization)	`CostOfRevenue`	$623.94M	USD	2 Qtrs
Direct cost of revenues (exclusive of depreciation and amortization)	`CostOfRevenue`	$337.23M	USD	1 Quarter
Direct cost of revenues (exclusive of depreciation and amortization)	`CostOfRevenue`	$673.74M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$102.43M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$47.33M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$92.76M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$52.36M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$5.30M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$5.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$10.60M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$11.41M	USD	2 Qtrs
Severance	`SeveranceCosts1`	$635.00K	USD	2 Qtrs
Severance	`SeveranceCosts1`	-	USD	2 Qtrs
Severance	`SeveranceCosts1`	$195.00K	USD	1 Quarter
Severance	`SeveranceCosts1`	-	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$727.30M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$363.54M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$788.21M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$395.52M	USD	1 Quarter
Other operating expense	`OtherGeneralExpense`	$1.62M	USD	2 Qtrs
Other operating expense	`OtherGeneralExpense`	$846.00K	USD	1 Quarter
Other operating expense	`OtherGeneralExpense`	$1.09M	USD	2 Qtrs
Other operating expense	`OtherGeneralExpense`	$889.00K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-397.00K	USD	2 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$8.31M	USD	2 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-480.00K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$3.13M	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$609.00K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$648.00K	USD	2 Qtrs
Interest income, net	`InterestIncomeExpenseNet`	$286.00K	USD	1 Quarter
Interest income, net	`InterestIncomeExpenseNet`	$309.00K	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$-456.00K	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$1.97M	USD	2 Qtrs
Other income (expense), net	`NonoperatingIncomeExpense`	$-419.00K	USD	1 Quarter
Other income (expense), net	`NonoperatingIncomeExpense`	$370.00K	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$176.00K	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.02M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-205.00K	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$10.90M	USD	2 Qtrs
Benefit from (provision for) income taxes	`IncomeTaxExpenseBenefit`	$1.76M	USD	1 Quarter
Benefit from (provision for) income taxes	`IncomeTaxExpenseBenefit`	$-12.65M	USD	2 Qtrs
Benefit from (provision for) income taxes	`IncomeTaxExpenseBenefit`	$-99.00K	USD	2 Qtrs
Benefit from (provision for) income taxes	`IncomeTaxExpenseBenefit`	$-1.51M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.26M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.69M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$23.55M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-106.00K	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$758.00K	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$382.00K	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$470.00K	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$174.00K	USD	1 Quarter
Net income (loss) attributable to IDT Corporation	`NetIncomeLoss`	$-576.00K	USD	2 Qtrs
Net income (loss) attributable to IDT Corporation	`NetIncomeLoss`	$875.00K	USD	1 Quarter
Net income (loss) attributable to IDT Corporation	`NetIncomeLoss`	$22.79M	USD	2 Qtrs
Net income (loss) attributable to IDT Corporation	`NetIncomeLoss`	$1.52M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.04	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.00	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.02	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.06	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.06	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.99	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.04	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	24.64M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	22.74M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	24.64M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	22.77M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	24.64M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	22.93M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	24.72M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	22.96M	shares	1 Quarter
Dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.38	USD	2 Qtrs
Dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.38	USD	2 Qtrs
Dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.19	USD	1 Quarter
Dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.19	USD	1 Quarter
(i) Stock-based compensation included in selling, general and administrative expenses	`ShareBasedCompensation`	$1.80M	USD	2 Qtrs
(i) Stock-based compensation included in selling, general and administrative expenses	`ShareBasedCompensation`	$1.43M	USD	1 Quarter
(i) Stock-based compensation included in selling, general and administrative expenses	`ShareBasedCompensation`	$987.00K	USD	1 Quarter
(i) Stock-based compensation included in selling, general and administrative expenses	`ShareBasedCompensation`	$2.13M	USD	2 Qtrs

Cash Flow Statement 84 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents`	$5.72M	USD	Point-in-time
Cash and cash equivalents	`DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents`	$6.29M	USD	Point-in-time
Net (loss) income	`ProfitLoss`	$1.26M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$1.69M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$23.55M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-106.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.30M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$5.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$10.60M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$11.41M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-12.87M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$3.21M	USD	2 Qtrs
Provision for doubtful accounts receivable	`ProvisionForDoubtfulAccounts`	$696.00K	USD	2 Qtrs
Provision for doubtful accounts receivable	`ProvisionForDoubtfulAccounts`	$126.00K	USD	2 Qtrs
Realized loss (gain) on marketable securities	`AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments`	$305.00K	USD	2 Qtrs
Realized loss (gain) on marketable securities	`AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments`	$-9.00K	USD	2 Qtrs
Interest in the equity of investments	`IncomeLossFromEquityMethodInvestments`	$77.00K	USD	2 Qtrs
Interest in the equity of investments	`IncomeLossFromEquityMethodInvestments`	$295.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.80M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$1.43M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$987.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$2.13M	USD	2 Qtrs
Restricted cash and cash equivalents	`IncreaseDecreaseInRestrictedCashForOperatingActivities`	$3.66M	USD	2 Qtrs
Restricted cash and cash equivalents	`IncreaseDecreaseInRestrictedCashForOperatingActivities`	$-4.10M	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.57M	USD	2 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$8.19M	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.43M	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$15.11M	USD	2 Qtrs
Trade accounts payable, accrued expenses, other current liabilities and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-20.34M	USD	2 Qtrs
Trade accounts payable, accrued expenses, other current liabilities and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-15.01M	USD	2 Qtrs
Customer deposits	`IncreaseDecreaseInCustomerDeposits`	$4.48M	USD	2 Qtrs
Customer deposits	`IncreaseDecreaseInCustomerDeposits`	$-1.18M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-2.04M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-4.71M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.97M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-814.00K	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.54M	USD	2 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.93M	USD	2 Qtrs
Proceeds from sale of interest in Straight Path IP Group Holding, Inc.	`RelatedPartyTransactionSaleToRelatedPartyAmount`	$6.00M	USD	Point-in-time
Proceeds from sale of interest in Straight Path IP Group Holding, Inc.	`RelatedPartyTransactionSaleToRelatedPartyAmount`	-	USD	2 Qtrs
Proceeds from sale of interest in Straight Path IP Group Holding, Inc.	`RelatedPartyTransactionSaleToRelatedPartyAmount`	$6.00M	USD	2 Qtrs
Purchase of IP Interest from Straight Path Communications Inc.	`LossContingencyPaymentForAssets`	-	USD	2 Qtrs
Purchase of IP Interest from Straight Path Communications Inc.	`LossContingencyPaymentForAssets`	$6.00M	USD	Point-in-time
Purchase of IP Interest from Straight Path Communications Inc.	`LossContingencyPaymentForAssets`	$6.00M	USD	2 Qtrs
Payment for acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Payment for acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$1.83M	USD	2 Qtrs
Cash used for investments	`PaymentsToAcquireInvestments`	-	USD	2 Qtrs
Cash used for investments	`PaymentsToAcquireInvestments`	$8.30M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$17.21M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$19.80M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$31.61M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$16.85M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$882.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-21.04M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividendsCommonStock`	$9.44M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividendsCommonStock`	$8.77M	USD	2 Qtrs
Distributions to noncontrolling interests	`PaymentsOfCapitalDistribution`	$817.00K	USD	2 Qtrs
Distributions to noncontrolling interests	`PaymentsOfCapitalDistribution`	$717.00K	USD	2 Qtrs
Proceeds from borrowings under revolving credit facility	`ProceedsFromLinesOfCredit`	$19.08M	USD	2 Qtrs
Proceeds from borrowings under revolving credit facility	`ProceedsFromLinesOfCredit`	-	USD	2 Qtrs
Repayments of borrowings under revolving credit facility	`RepaymentsOfLinesOfCredit`	-	USD	2 Qtrs
Repayments of borrowings under revolving credit facility	`RepaymentsOfLinesOfCredit`	$19.08M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$835.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from sale of member interests in CS Pharma Holdings, LLC.	`ProceedsFromSaleOfInterestInLimitedLiabilityCompany`	-	USD	2 Qtrs
Proceeds from sale of member interests in CS Pharma Holdings, LLC.	`ProceedsFromSaleOfInterestInLimitedLiabilityCompany`	$1.25M	USD	2 Qtrs
Repurchases of Class B common stock	`PaymentsForRepurchaseOfCommonStock`	$1.84M	USD	2 Qtrs
Repurchases of Class B common stock	`PaymentsForRepurchaseOfCommonStock`	$61.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-9.34M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-10.22M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-829.00K	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$592.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-32.01M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-35.72M	USD	2 Qtrs
Cash and cash equivalents at beginning of period, including $5,716 held for sale at July 31, 2017	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$96.06M	USD	Point-in-time
Cash and cash equivalents at beginning of period, including $5,716 held for sale at July 31, 2017	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$109.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period, including $5,716 held for sale at July 31, 2017	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$77.52M	USD	Point-in-time
Cash and cash equivalents at beginning of period, including $5,716 held for sale at July 31, 2017	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$60.34M	USD	Point-in-time
Cash and cash equivalents at end of period, including $6,287 held for sale at January 31, 2018	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$96.06M	USD	Point-in-time
Cash and cash equivalents at end of period, including $6,287 held for sale at January 31, 2018	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$109.54M	USD	Point-in-time
Cash and cash equivalents at end of period, including $6,287 held for sale at January 31, 2018	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$77.52M	USD	Point-in-time
Cash and cash equivalents at end of period, including $6,287 held for sale at January 31, 2018	`CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations`	$60.34M	USD	Point-in-time
Reclassification of liability for member interests in CS Pharma Holdings, LLC	`ReclassificationOfLiabilityForMemberInterestsInCsPharmaHoldingsLlc`	-	USD	2 Qtrs
Reclassification of liability for member interests in CS Pharma Holdings, LLC	`ReclassificationOfLiabilityForMemberInterestsInCsPharmaHoldingsLlc`	$8.75M	USD	2 Qtrs

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`ProfitLoss`	$1.26M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$1.69M	USD	1 Quarter
Net (loss) income	`ProfitLoss`	$23.55M	USD	2 Qtrs
Net (loss) income	`ProfitLoss`	$-106.00K	USD	2 Qtrs
Change in unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-63.00K	USD	2 Qtrs
Change in unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-120.00K	USD	1 Quarter
Change in unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-40.00K	USD	1 Quarter
Change in unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-150.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-2.40M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$459.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-38.00K	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$330.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.47M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$419.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-188.00K	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$210.00K	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.68M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.90M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$21.09M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-294.00K	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$174.00K	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$382.00K	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$758.00K	USD	2 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$470.00K	USD	2 Qtrs
Comprehensive income (loss) attributable to IDT Corporation	`ComprehensiveIncomeNetOfTax`	$1.73M	USD	1 Quarter
Comprehensive income (loss) attributable to IDT Corporation	`ComprehensiveIncomeNetOfTax`	$-764.00K	USD	2 Qtrs
Comprehensive income (loss) attributable to IDT Corporation	`ComprehensiveIncomeNetOfTax`	$20.33M	USD	2 Qtrs
Comprehensive income (loss) attributable to IDT Corporation	`ComprehensiveIncomeNetOfTax`	$1.29M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.